Ondansetron
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68788-7644 -
Package NDC
68788-7644-1 -
Package NDC
68788-7644-3 -
Package NDC
68788-7644-5 -
Application number
ANDA090469 -
SPL ID
363d7c61-cc6b-40bf-9cde-3396a42b1caa -
SPL set ID
66ac9c17-bea7-4f8d-8a27-a1e0f9e65945 -
UNII
4AF302ESOS -
RxCUI
104894
What the source publishes
- Labeler
- Preferred Pharmaceuticals, Inc.
- Active ingredients
- Ondansetron
- Form
- TABLET, ORALLY DISINTEGRATING
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ondansetron",
"splId": "363d7c61-cc6b-40bf-9cde-3396a42b1caa",
"labels": [
{
"setId": "66ac9c17-bea7-4f8d-8a27-a1e0f9e65945",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66ac9c17-bea7-4f8d-8a27-a1e0f9e65945",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=66ac9c17-bea7-4f8d-8a27-a1e0f9e65945"
}
],
"routes": [
"ORAL"
],
"labeler": "Preferred Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68788-7644-1)",
"package_ndc": "68788-7644-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20200228"
},
{
"sample": false,
"description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68788-7644-3)",
"package_ndc": "68788-7644-3",
"identifierStatus": "well-formed",
"marketing_start_date": "20200228"
},
{
"sample": false,
"description": "5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68788-7644-5)",
"package_ndc": "68788-7644-5",
"identifierStatus": "well-formed",
"marketing_start_date": "20200228"
}
],
"productId": "68788-7644_363d7c61-cc6b-40bf-9cde-3396a42b1caa",
"useDomain": "unknown",
"dosageForm": "TABLET, ORALLY DISINTEGRATING",
"productNdc": "68788-7644",
"deaSchedule": null,
"genericName": "Ondansetron",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ONDANSETRON",
"strength": "4 mg/1"
}
],
"applicationNumber": "ANDA090469",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200228",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175817",
"N0000175818"
],
"unii": [
"4AF302ESOS"
],
"rxcui": [
"104894"
],
"spl_set_id": [
"66ac9c17-bea7-4f8d-8a27-a1e0f9e65945"
],
"pharm_class_epc": [
"Serotonin-3 Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Serotonin 3 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Preferred Pharmaceuticals, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68788-7644_363d7c61-cc6b-40bf-9cde-3396a42b1caa"